Triatomic Management’s Doximity DOCS Stock Holding History

Triatomic Management’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,001	Closed	-$1.6M	–	44
2021 Q4	$1.6M	Buy	+32,001	New	+$2.08M	0.98%	28

Other funds holding DOCS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Triatomic Management's DOCS Position: Q1 2022 in Review

Triatomic Management sold out of Doximity (DOCS) in Q1 2022, closing a stake of 32,001 shares — an estimated $1.6M sold.

Triatomic Management first reported a position in DOCS in Q4 2021 and held it in 1 quarter. The position peaked at $1.6M in Q4 2021. 218 funds tracked by Wall St. Rank hold DOCS as of Q1 2022.

Triatomic Management reported no remaining Doximity position as of Q1 2022 after selling out during the quarter.
Triatomic Management sold 32,001 Doximity shares in Q1 2022, an estimated $1.6M.
Triatomic Management first reported a position in Doximity in Q4 2021 and held it in 1 quarter.
Triatomic Management's Doximity position peaked at $1.6M in Q4 2021.
218 funds tracked by Wall St. Rank held Doximity as of Q1 2022.

Based on Triatomic Management's 13F filing for Q1 2022, filed 12 May 2022.